ASSTNasdaqFinance ServicesFiscal year ends December 31Also trades as SATA, SATS
Strive, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$25.54+1.45 (+6.02%)
Close on Oct 19, 2026
- Market cap
- $1.92B
- P/E (TTM)
- –
- Dividend yield
- –
Strive, Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Management | $1.51M | $1.35M | $1.50M | – | $1.49M | $1.42M | $1.04M | $984.00K | 51.4% | +1.6% |
| Medical Device | $1.39M | $1.37M | – | – | $0 | $0 | – | – | 47.2% | – |
| Corporate & Other | $41.00K | $43.00K | $17.00K | – | $23.00K | $0 | $0 | $0 | 1.4% | +78.3% |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Asset Management | -$2.16M | -$2.01M | -$5.95M | – | -$1.88M | -$4.07M | -$4.69M | -$7.01M | +14.9% |
| Medical Device | -$5.22M | -$6.11M | – | – | $0 | $0 | – | – | – |
| Corporate & Other | -$250.88M | -$305.03M | -$235.18M | – | -$1.81M | $0 | $0 | $0 | +13730.1% |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Investment advisory fees | $1.51M | $1.35M | $1.50M | – | $1.49M | $1.42M | $1.03M | $950.00K | 51.4% | +1.6% |
| Medical device revenues | $1.39M | $1.37M | – | – | $0 | $0 | – | – | 47.2% | – |
| Other revenue | $41.00K | $43.00K | $17.00K | – | $23.00K | $7.00K | $3.00K | $34.00K | 1.4% | +78.3% |
By region
From the segment and revenue-disaggregation notes of Strive's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.